# Lapatinib ditosylate

## Tykerb 250mg

#### 個案臨採

| 藥品代碼       | OTYK                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:---------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | In combination w/ capecitabine for the treatment of patients w/ advanced/metastatic breast cancer whose tumours overexpress HER2 & who have received prior therapy including anthracycline， taxane & trastuzumab. In combination w/ letrozole for the treatment of post-menopausal women w/ hormone receptor positive metastatic breast cancer that overexpress HER2 receptor for whom hormonal therapy is indicated.                                                                                                                                                                 |
| 用法用量       | Monitor left ventricular ejection fraction (baseline and periodic) before and during therapy. TYKERB should be taken at least one hour before or one hour after a meal. [Advanced/metastatic breast cancer] 1250 mg (5 tablets) once daily on Days 1-21 continuously in combination with capecitabine 2，000 mg/m2/day (administered orally in 2 doses approximately 12 hours apart) on Days 1-14 in a repeating 21 day cycle. [Hormone receptor (+)， HER2 (+) metastatic breast cancer] 1500 mg (6 tablets) once daily continuously in combination with letrozole 2.5 mg once daily. |
| 肝功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 禁忌           | Hypersensitivity to lapatinib ditosylate or to any of the excipients of Tykerb                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 副作用         | Anorexia， diarrhea， nausea， vomiting， rash， fatigue， dyspepsia， dry skin， stomatitis， constipation， abdominal pain， palmar-plantar erythrodysesthesia， mucosal inflammation， pain in extremity， back pain， insomnia， epistaxis， alopecia; decreased LVEF， nail disorders， headache.                                                                                                                                                                                                                                                                                 |
| 孕期用藥建議   | nan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 哺乳期用藥建議 | nan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

